In evaluating diagnostic test studies, which item is considered a fatal flaw in critical appraisal?

In evaluating diagnostic test studies, which item is considered a fatal flaw in critical appraisal?

• A. Not comparing results from index to gold standard
• B. Index tests not interpreted blindly to the gold standard and vice versa
• C. Not all subjects underwent comparison
• D. Time between index tests not short enough

Answer: (B)

Interpretation bias from lack of blinding is a major threat to validity in diagnostic test studies. When those evaluating the index test know the results of the reference standard (and vice versa), their judgments can be unconsciously swayed by the disease status. This bias can lead to misclassification of true disease status and inflate measures of diagnostic accuracy such as sensitivity and specificity. Because this bias directly contaminates the fundamental outcome of interest—the test’s performance—it’s considered a fatal flaw in critical appraisal. Other issues matter, too—if not all subjects are confirmed with the gold standard, or if the two tests are separated by a long time allowing disease to change, those introduce verification or timing biases and affect applicability or precision. But without proper blinding in both directions, the study’s internal validity is compromised in a way that more readily distorts the results than these other concerns.

Interpretation bias from lack of blinding is a major threat to validity in diagnostic test studies. When those evaluating the index test know the results of the reference standard (and vice versa), their judgments can be unconsciously swayed by the disease status. This bias can lead to misclassification of true disease status and inflate measures of diagnostic accuracy such as sensitivity and specificity. Because this bias directly contaminates the fundamental outcome of interest—the test’s performance—it’s considered a fatal flaw in critical appraisal.

Other issues matter, too—if not all subjects are confirmed with the gold standard, or if the two tests are separated by a long time allowing disease to change, those introduce verification or timing biases and affect applicability or precision. But without proper blinding in both directions, the study’s internal validity is compromised in a way that more readily distorts the results than these other concerns.